Every cancer patient deserves the right treatment
for their individual form of cancer.
New The power of precision, For Every Oncologist, Today
With IndiTreat, 2cureX makes the testing of chemotherapeutic agents on patient-derived microtumors an operational reality.
2cureX has signed a distribution agreement with specialized diagnostic solutions leader Werfen, to distribute 2cureX products in Spain
For over 2 decades, testing cancer treatments on microtumors rather than on the patient has been on the horizon. With IndiTreat®, 2cureX makes microtumor testing an operational reality to serve you and your cancer clinic.
IndiTreat CE IVD is available today for identifying effective chemotherapies of certain forms of colorectal cancer if a biopsy is feasible. Ask your doctor if it is possible to consider IndiTreat for your cancer.
Press Releases Regulatory
2cureX publishes interim report for the second quarter and first half of 2021
2cureX offentliggör delårsrapport för det andra kvartalet och första halvåret 2021
New development of the IndiTreat® technology allows prediction of response to anti-angiogenic drugs in colorectal cancer.
Upcoming events in the fall from 2cureX
Get notified on mail, when news or press releases are posted on our website